store at -20°C
Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Labetuzumab govitecan is an anti-CEACAM5/SN-38 antibody-drug conjugate for therapy of refractory or relapsing metastatic colorectal cancer. |
Synonyms | IMMU-130, Labetuzumab-SN38, hMN14-SN38, IMMU130, IMMU 130 |
Molecular Weight | 1587.76 |
Formula | C75H102N12O24S |
CAS No. | 1469876-18-3 |
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Labetuzumab govitecan 1469876-18-3 Others IMMU-130 Labetuzumab-SN38 hMN14-SN38 IMMU130 IMMU 130 inhibitor inhibit